Satsuma Pharmaceuticals, Inc.
STSADelisted Jun 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001692830
Satsuma Pharmaceuticals, Inc. was delisted on Jun 8, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 31 institutions reported holding it in 13F filings for Q1 2023, worth $12.7M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Satsuma Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 33 | 31 | −2 |
| Shares | 19.8M | 18.3M | −1.58M (−8.0%) |
| Value | $17.8M | $12.7M | −$5.10M (−28.6%) |
New holders (5)
Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lion Point Capital, LP | 319,742 | $223.3K | 0.12% |
| FNY Investment Advisers, LLC | 46,187 | $32.0K | 0.04% |
| Advisor Group Holdings, Inc. | 16,000 | $11.2K | 0.00% |
| Tower Research Capital LLC (TRC) | 8,280 | $6.00K | 0.00% |
| UBS Group AG | 1,815 | $1.27K | 0.00% |
Sold out (7)
Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Driehaus Capital Management LLC | 816,902 | $735.2K |
| Dimensional Fund Advisors LP | 231,417 | $209.0K |
| Millennium Management LLC | 174,994 | $157.0K |
| Chicago Partners Investment Group LLC | 63,863 | $54.3K |
| Susquehanna International Group, LLP | 54,419 | $49.0K |
| Two Sigma Securities, LLC | 24,972 | $22.5K |
| FMR LLC | 45 | $41 |